- |||||||||| Paxlovid (nirmatrelvir and ritonavir) / Pfizer
¿Paxlovid (Pfizer)? (Twitter) - Jan 14, 2022
- |||||||||| Paxlovid (nirmatrelvir and ritonavir) / Pfizer
Paxlovid? (Twitter) - Jan 14, 2022
- |||||||||| Actemra IV (tocilizumab) / Roche, JW Pharma
Review, Journal: The need for a multi-level drug targeting strategy to curb the COVID-19 pandemic. (Pubmed Central) - Jan 14, 2022 Several drugs have been identified that can fit this potential role by targeting different stages of COVID-19 including baricitinib, molnupiravir and PF-07321332/ritonavir and also the combination of deferiprone with N-acetylcysteine for inhibiting the vicious circle of oxidative stress toxicity and endothelial cell damage. Most of these drugs are expected to be effective against all the SARS-CoV-2 variants including Omicron (B.1.1.529) and also the associated COVID-19 complications.
|